Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP)
- 11 February 2020
- journal article
- research article
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 20 (6) , 591-602
Abstract
The aim was to evaluate the risk of cardiovascular-specific hospitalizations with different types of antihypertensive triple combination therapy among patients enrolled in a Medicare Advantage Plan (MAP).Keywords
This publication has 43 references indexed in Scilit:
- Associations of Preexisting Depression and Anxiety With Hospitalization in Patients With Cardiovascular DiseaseMayo Clinic Proceedings, 2011
- Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensivesCurrent Medical Research and Opinion, 2010
- Combination therapy for the management of hypertension: A review of the evidenceAmerican Journal of Health-System Pharmacy, 2010
- Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinationsCurrent Medical Research and Opinion, 2008
- Risk Factors for Hospitalization Among Community-Dwelling Primary Care Older PatientsMedical Care, 2008
- Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ, 2008
- Management of Hypertension in DiabetesDiabetes Spectrum, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Assessing Medication Adherence in the ElderlyDrugs & Aging, 2005
- Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe TrialJournal Of Hypertension, 2004